Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer L Bishop

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Oncotarget|November 28, 2014
PD-L1 is highly expressed in Enzalutamide resistant prostate cancerJennifer L Bishop, Alexander Sio, Arkhjamil Angeles, et al.
Journal of Molecular Endocrinology|April 24, 2019
PEG10 is associated with treatment-induced neuroendocrine prostate cancerSoojin Kim, Daksh Thaper, Samir Bidnur, et al.
International Journal of Cancer|August 19, 2014
Hsp27 regulates EGF/β-catenin mediated epithelial to mesenchymal transition in prostate cancerThomas Cordonnier, Jennifer L Bishop, Masaki Shiota, et al.
Oncotarget|April 15, 2015
Inhibition of the HER2-YB1-AR axis with Lapatinib synergistically enhances Enzalutamide anti-tumor efficacy in castration resistant prostate cancerMasaki Shiota, Jennifer L Bishop, Ario Takeuchi, et al.
The Prostate|November 1, 2014
Beyond immune checkpoint blockade: new approaches to targeting host-tumor interactions in prostate cancer: report from the 2014 Coffey-Holden prostate cancer academy meetingAndrea K Miyahira, Haydn T Kissick, Jennifer L Bishop, et al.
Infection and Immunity|December 13, 2006
SseL is a salmonella-specific translocated effector integrated into the SsrB-controlled salmonella pathogenicity island 2 type III secretion systemBrian K Coombes, Michael J Lowden, Jennifer L Bishop, et al.
Cancer Research|March 16, 2013
Hsp27 regulates epithelial mesenchymal transition, metastasis, and circulating tumor cells in prostate cancerMasaki Shiota, Jennifer L Bishop, Ka Mun Nip, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2014
Lyn deficiency leads to increased microbiota-dependent intestinal inflammation and susceptibility to enteric pathogensMorgan E Roberts, Jennifer L Bishop, Xueling Fan, et al.
Stapp Car Crash Journal|December 17, 2008
Mechanisms of traumatic rupture of the aorta and associated peri-isthmic motion and deformationWarren N Hardy, Chirag S Shah, Matthew J Mason, et al.
Cancer Discovery|October 28, 2016
The Master Neural Transcription Factor BRN2 Is an Androgen Receptor-Suppressed Driver of Neuroendocrine Differentiation in Prostate CancerJennifer L Bishop, Daksh Thaper, Sepideh Vahid, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Oncotarget|November 28, 2014
PD-L1 is highly expressed in Enzalutamide resistant prostate cancerJennifer L Bishop, Alexander Sio, Arkhjamil Angeles, et al.
Journal of Molecular Endocrinology|April 24, 2019
PEG10 is associated with treatment-induced neuroendocrine prostate cancerSoojin Kim, Daksh Thaper, Samir Bidnur, et al.
International Journal of Cancer|August 19, 2014
Hsp27 regulates EGF/β-catenin mediated epithelial to mesenchymal transition in prostate cancerThomas Cordonnier, Jennifer L Bishop, Masaki Shiota, et al.
Oncotarget|April 15, 2015
Inhibition of the HER2-YB1-AR axis with Lapatinib synergistically enhances Enzalutamide anti-tumor efficacy in castration resistant prostate cancerMasaki Shiota, Jennifer L Bishop, Ario Takeuchi, et al.
The Prostate|November 1, 2014
Beyond immune checkpoint blockade: new approaches to targeting host-tumor interactions in prostate cancer: report from the 2014 Coffey-Holden prostate cancer academy meetingAndrea K Miyahira, Haydn T Kissick, Jennifer L Bishop, et al.
Infection and Immunity|December 13, 2006
SseL is a salmonella-specific translocated effector integrated into the SsrB-controlled salmonella pathogenicity island 2 type III secretion systemBrian K Coombes, Michael J Lowden, Jennifer L Bishop, et al.
Cancer Research|March 16, 2013
Hsp27 regulates epithelial mesenchymal transition, metastasis, and circulating tumor cells in prostate cancerMasaki Shiota, Jennifer L Bishop, Ka Mun Nip, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2014
Lyn deficiency leads to increased microbiota-dependent intestinal inflammation and susceptibility to enteric pathogensMorgan E Roberts, Jennifer L Bishop, Xueling Fan, et al.
Stapp Car Crash Journal|December 17, 2008
Mechanisms of traumatic rupture of the aorta and associated peri-isthmic motion and deformationWarren N Hardy, Chirag S Shah, Matthew J Mason, et al.
Cancer Discovery|October 28, 2016
The Master Neural Transcription Factor BRN2 Is an Androgen Receptor-Suppressed Driver of Neuroendocrine Differentiation in Prostate CancerJennifer L Bishop, Daksh Thaper, Sepideh Vahid, et al.
Pageof 2